Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CHKA | P35790 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.39 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TET3 | O43151 | 2/20 | 0.36 |
| ▸ | FBXL19 | Q6PCT2 | 2/20 | 0.36 |
| ▸ | CXXC5 | Q7LFL8 | 2/20 | 0.36 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.36 |
| ▸ | CXXC4 | Q9H2H0 | 2/20 | 0.36 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18626274 | 0.96 | CA2 (0.43) | CA2CHKACA12CA1CA9 | |
| SCHEMBL277853 | 0.92 | CA2 (0.48) | CA2CHKACA12CA1CA9 | |
| Hydrochloric Acid SCHEMBL17397450 | 0.90 | CA2 (0.46) | CA2CHKACA12CA1CA9 | |
| Formamide SCHEMBL28191106 | 0.84 | CA2 (0.42) | CA2CHKACA12CA1CA9 | |
| SCHEMBL1591923 | 0.80 | — | — | |
| SCHEMBL149678 | 0.80 | — | — | |
| SCHEMBL505654 | 0.80 | ALDH1A1 (0.48) | KMT2AMEN1TET3FBXL19CXXC5 | |
| SCHEMBL2657029 | 0.80 | CA2 (0.50) | CA2CHKACA12CA1CA9 | |
| Trifluoroacetic Acid SCHEMBL28639089 | 0.79 | PKM (0.43) | CA2CHKACA12CA1CA9 | |
| Trifluoroacetic Acid SCHEMBL20296564 | 0.79 | PKM (0.43) | CA2CHKACA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383884-A1 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS, INC. | 2024-11-21 | — | — | US | disclosed |
| CN-112203742-B | Membrane containing polymeric ionic liquid for gas separation | 国家研究委员会 | 2023-07-28 | — | — | CN | disclosed |
| CN-115244089-A | Membrane and use thereof | 富士胶片制造欧洲有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-115210270-A | Membrane and use thereof | 富士胶片制造欧洲有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-115151580-A | Film laminate and use thereof | 富士胶片制造欧洲有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-114599728-A | Surface-modified film | 富士胶片制造欧洲有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-107849275-B | Ion exchange membrane | 富士胶片制造欧洲有限公司 | 2021-11-02 | — | — | CN | disclosed |
| CN-112203742-A | Membranes containing polymeric ionic liquids for gas separation | 国家研究委员会 | 2021-01-08 | — | — | CN | disclosed |
| CN-107849274-B | Ion exchange membrane | 富士胶片制造欧洲有限公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-107207878-B | Curable composition and film | 富士胶片制造欧洲有限公司 | 2020-08-14 | — | — | CN | disclosed |
| US-8852640-B2 | Micelles for delivery of nitric oxide | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2014-10-07 | — | — | US | disclosed |
| CN-103717296-A | Composite membrane | FUJIFILM MFG EUROPE BV | 2014-04-09 | — | — | CN | disclosed |
| WO-2010002450-A2 | MICELLES FOR DELIVERY OF NITRIC OXIDE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2010-01-07 | — | — | WO | disclosed |
| US-20100003338-A1 | Micelles for delivery of nitric oxide | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2010-01-07 | — | — | US | disclosed |
| US-5559109-A | Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist | SANKKO COMPANY, LIMITED (JP) | 1996-09-24 | — | — | US | disclosed |
| US-5556852-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0395446-B1 | N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists | SANKYO CO (JP) | 1995-03-01 | — | — | EP | disclosed |
| US-5369106-A | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists | SANKYO COMPANY, LIMITED (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5192766-A | Platelet activating factor antagonist | SANKYO COMPANY, LIMITED (JP) | 1993-03-09 | — | — | US | disclosed |
| EP-0395446-A2 | N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists | Sankyo Company Limited (JP) | 1990-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003338-A1 | Micelles for delivery of nitric oxide | NOS2, NOS1, NOS3 | CA2 893/4885CHKA 485/4885CA12 524/4885 |
| US-20240383884-A1 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | IL2, NFATC1, IL2RA | CA2 1859/4885CHKA 298/4885CA12 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.